Restless legs syndrome and hashimoto's thyroiditis

Area of Science:

• Endocrinology
• Neurology
• Sleep Medicine

Background:

• Hypothesized link between thyroid hormone imbalance and dopaminergic activity in Restless Legs Syndrome (RLS) development.
• Hashimoto's thyroiditis, an autoimmune thyroid disease, may be associated with RLS.
• Investigating RLS in Hashimoto's patients and the effect of thyroid hormone replacement therapy.

Purpose of the Study:

• To evaluate the incidence and severity of RLS in Hashimoto's thyroiditis patients.
• To compare RLS in untreated Hashimoto's, treated Hashimoto's, and healthy control groups.
• To assess the impact of thyroid hormone replacement therapy on RLS in Hashimoto's patients.

Main Methods:

• 120 participants: 80 with Hashimoto's (40 untreated, 40 treated) and 40 healthy controls.
• RLS diagnosis based on International Restless Legs Syndrome Study Group (IRLSSG) criteria.
• RLS symptom severity assessed using the Restless Legs Syndrome Severity Rating Scale (RLS-SRS).

Main Results:

• Significantly higher RLS symptoms and RLS-SRS scores in Hashimoto's patients versus controls (p < 0.01).
• Untreated Hashimoto's group showed markedly higher RLS incidence and severity than treated group and controls (p < 0.001).
• No significant RLS difference between treated Hashimoto's group and controls; RLS severity correlated with Hashimoto's duration (p = 0.03).

Conclusions:

• RLS is more prevalent and severe in individuals with untreated Hashimoto's thyroiditis.
• Thyroid hormone replacement therapy appears to play a protective role against RLS in this population.
• Treatment of hypothyroidism may be beneficial in managing RLS symptoms in Hashimoto's patients.